Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices | Global Markets

107 Pages | 57 Exhibits | 2018 Analysis | Forecasts Through 2022
Buy Now
Become Market Insider

Overview

This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for peripheral vascular disease (PVD) therapeutic devices.

CARDIOLOGY MARKET HIGHLIGHTS

  • Total unit sales for PVD therapeutic devices are steadlily increasing due to a number of factors, including: the increasing prevalence of CVD and PVD, advances in CVD diagnostics to better identify candidates for surgery, and demand for minimally invasive interventional therapies to treat patients requiring surgical interventions to manage their conditions.
  • In 2017, vascular stents accounted for the majority of PVD therapeutic device sales. Vascular stent sales are projected to experience the strongest growth during the forecast period (2017-22) due to the introduction of drug-eluting stents for the treatment of PVD and demand in emerging markets
  • The global market for PVD therapeutic devices is anticipated to increase at a CAGR of 7.2% during the forecast period, reaching approximately $5,876.6m in total product sales by 2022.
  • The US was the largest market for PVD therapeutic device sales in 2017. Sales of PVD therapeutic devices to the US accounted for approximately 39.6% of all product sales in 2017. Meddevicetracker estimates that the rest of the world (RoW) segment will see the strongest growth throughout the forecast period.
  • Angioplasty catheters and vascular stents are the primary therapies for the treatment of PVD, due to the abundance of data supporting the safety and efficacy of these devices in the treatment of PVD.

 

TOPICS COVERED INCLUDE:

  • An overview of minimally invasive devices for the treatment of PVD, including: angioplasty catheters, atherectomy catheters, CTO crossing devices, thromboembolectomy catheters, and vascular stents.
  • Global and country/region-specific market forecasts, including forecasts by product segment.
  • Competitive analyses by product segment.
  • Discussion of key drivers and limiters impacting the major product segments
  • Primary research with interventional cardiologists from the US, five major EU markets, and Japan focused on how physicians are utilizing these devices and their preferred/most frequently utilized manufacturers.
  • A review of emerging technologies which could impact sales of existing devices.

Table of Contents


Executive Summary 

i. Peripheral vascular disease overview
ii. Global peripheral vascular disease therapeutic devices market 
a. Market drivers and limiters
b. Device segment insights 
c. Technology trends
d. Market leaders
e. Competitive strategies
f. Emerging competition 
iii. Methodology
iv. Bibliography 

Exhibit ES-1: PVD therapeutic devices, global market forecast ($m), 2017-22 
Exhibit ES-2: Global PVD therapeutic devices market, share by country/region, 2017 
Exhibit ES-3: Drivers and limiters of market growth - vascular access site closure products

1. Peripheral Vascular Disease Overview

1.1 Critical limb ischemia 
1.2 Aneurysm
1.3 Deep vein thrombosis/pulmonary embolism
1.4 Diagnosis and treatment
1.5 Bibliography 

Exhibit 1-1: Estimated prevalence of peripheral artery disease, select countries, 2016 
Exhibit 1-2: Estimated incident cases of DVT, select countries, 2017 
Exhibit 1-3: Estimated incident cases of PE, select countries, 2017

2. Peripheral Vascular Disease Therapeutic Products
 
2.1 Angioplasty catheters 
2.1.1 Balloon angioplasty products 
2.1.2 Drug-coated balloon catheter products 
2.1.3 Cutting and scoring balloon catheter products
2.2 Vascular stents
2.2.1 Bare-metal stents
2.2.2 Drug-eluting stents 
2.2.3 Bioabsorbable stents and bioresorbable vascular scaffolds
2.3 Atherectomy catheters
2.4 Thromboembolectomy catheters
2.5 Chronic total occlusion therapy devices
2.6 Bibliography 

3. Peripheral Vascular Disease Therapeutic Devices Market

3.1 Global market insights
3.1.1 Market value
3.1.2 Technology trends 
3.1.3 Market drivers and limiters 
3.1.4 PVD therapeutic devices overview 
3.1.5 Market leaders
3.1.6 Competitive strategies
3.1.7 Emerging competition 
3.2 Global competitors 
3.2.1 Angioplasty catheters
3.2.2 Vascular stents
3.2.3 Atherectomy catheters
3.2.4 Thrombectomy catheters 
3.2.5 CTO crossing devices
3.3 Market forecast
3.3.1 Market forecast: US 
3.3.2 Market forecast: five major EU markets
3.3.3 Market forecast: Japan 
3.3.4 Market forecast: Rest of the world
3.4 Bibliography 

Exhibit 3-1: PVD therapeutic devices, global market forecast ($m), 2017-22
Exhibit 3-2: Global PVD therapeutic device market, market forecast ($m), by product segment, 2017-22 
Exhibit 3-3: Global PVD therapeutic device sales, share by product segment, 2017 
Exhibit 3-4: Global PVD therapeutic devices market, share by country/region, 2017 
Exhibit 3-5: Global PVD therapeutic device sales, combined market forecast ($m), by country/region, 2017-22
Exhibit 3-6: Drivers and limiters of market growth - vascular access site closure products
Exhibit 3-7: Estimated average sale price, selected angioplasty catheters, 2017 
Exhibit 3-8: Estimated average sale price, selected vascular stents, 2017
Exhibit 3-9: Angioplasty catheters market, share by supplier, 2017 
Exhibit 3-10: Vascular stents market, share by supplier, 2017
Exhibit 3-11: Atherectomy devices market, share by supplier, 2017 
Exhibit 3-12: Thrombectomy devices market, share by supplier, 2017 
Exhibit 3-13: US PVD therapeutic device sales, estimated market forecast ($m), by product type, 2017-22
Exhibit 3-14: US percutaneous transluminal angioplasty, procedure volumes forecast (000s), 2017-22 
Exhibit 3-15: US percutaneous transluminal angioplasty catheter sales, market forecast ($m), 2017-22 
Exhibit 3-16: US peripheral vascular stent implantation, procedure volumes forecast (000s), 2017-22
Exhibit 3-17: US peripheral vascular stent sales, market forecast ($m), 2017-22
Exhibit 3-18: US peripheral atherectomy, procedure volumes forecast (000s), 2017-22
Exhibit 3-19: US peripheral atherectomy device sales, market forecast ($m), 2017-22
Exhibit 3-20: US peripheral thrombectomy, procedure volumes forecast (000s), 2017-22
Exhibit 3-21: US peripheral thrombectomy sales, market forecast ($m), 2017-22
Exhibit 3-22: US chronic total occlusion, procedure volumes forecast (000s), 2017-22
Exhibit 3-23: US CTO crossing device sales, market forecast ($m), 2017-22
Exhibit 3-24: 5EU PVD therapeutic device sales, estimated market forecast ($m), by product type, 2017-22 
Exhibit 3-25: 5EU percutaneous transluminal angioplasty, procedure volumes forecast (000s), 2017-22
Exhibit 3-26: 5EU percutaneous transluminal angioplasty catheter sales, market forecast ($m), 2017-22 
Exhibit 3-27: 5EU peripheral vascular stent implantation, procedure volumes forecast (000s), 2017-22
Exhibit 3-28: 5EU peripheral vascular stent sales, market forecast ($m), 2017-22
Exhibit 3-29: 5EU peripheral atherectomy, procedure volumes forecast (000s), 2017-22
Exhibit 3-30: 5EU peripheral atherectomy device sales, market forecast ($m), 2017-22
Exhibit 3-31: 5EU peripheral thrombectomy, procedure volumes forecast (000s), 2017-22 
Exhibit 3-32: 5EU peripheral thrombectomy sales, market forecast ($m), 2017-22
Exhibit 3-33: 5EU chronic total occlusion, procedure volumes forecast (000s), 2017-22
Exhibit 3-34: 5EU CTO crossing device sales, market forecast ($m), 2017-22
Exhibit 3-35: Japanese PVD therapeutic device sales, estimated market forecast ($m), by product type, 2017-22 
Exhibit 3-36: Japanese percutaneous transluminal angioplasty, procedure volumes forecast (000s), 2017-22
Exhibit 3-37: Japanese percutaneous transluminal angioplasty catheter sales, market forecast ($m), 2017-22 
Exhibit 3-38: Japanese peripheral vascular stent implantation, procedure volumes forecast (000s), 2017-22
Exhibit 3-39: Japanese peripheral vascular stent sales, market forecast ($m), 2017-22 
Exhibit 3-40: Japanese peripheral atherectomy, procedure volumes forecast (000s), 2017-22
Exhibit 3-41: Japanese peripheral atherectomy device sales, market forecast ($m), 2017-22
Exhibit 3-42: Japanese peripheral thrombectomy, procedure volumes forecast (000s), 2017-22 
Exhibit 3-43: Japanese peripheral thrombectomy sales, market forecast ($m), 2017-22 
Exhibit 3-44: Japanese chronic total occlusion, procedure volumes forecast (000s), 2017-22
Exhibit 3-45: Japanese CTO crossing device sales, market forecast ($m), 2017-22 
Exhibit 3-46: RoW PVD therapeutic device sales, estimated market forecast ($m), by product type, 2017-22 
Exhibit 3-47: RoW percutaneous transluminal angioplasty catheter sales, market forecast ($m), 2017-22
Exhibit 3-48: RoW peripheral vascular stent sales, market forecast ($m), 2017-22 
Exhibit 3-49: RoW peripheral atherectomy device sales, market forecast ($m), 2017-22
Exhibit 3-50: RoW peripheral thrombectomy sales, market forecast ($m), 2017-22 
Exhibit 3-51: RoW CTO crossing device sales, market forecast ($m), 2017-22 

Appendix: Company Listing

Companies Covered

480 Biomedical
Aachen Resonance
Abbott
Acandis
Acrostak
Akesys Medical
Alvimedica
AMG International
AngioDynamics
Argon Medical Devices
ARTHESYS
Asahi Intecc
Avinger
B. Braun Melsungen
Balton
BD
Biosensors International
BIOTRONIK
Boston Scientific
C.R. Bard/BD
Cardio Flow
Capture Vascular
Cardionovum
Cardiovascular Systems
Cook Medical/Cook Group
Cordis/Cardinal Health
Edwards Lifesciences
Elixir Medical
Endocor
eucatech
Eurocor/Opto Circuits Group
Eximo Medical
Hexacath
IMeSI Italia
Inari Medical
iVascular
Kyoto Medical Planning
Lepu Medical
Medinol
Medtronic
MicroPort Scientific
Minvasys/STENTYS
Natec Medical
Philips
Penumbra
Ra Medical Systems
REVA Medical
Rex Medical
Rontis
Scitech
SIS Medical/Schwager Medica
STENTYS
Spectranetics/Philips
Straub Medical
Stryker
SurModics
Terumo Interventional Systems
Tokai Medical
Vascular Concepts
VentureMed Group
Walk Vascular
W.L Gore